$7.20
3.00%
Nasdaq, Sep 18, 04:00 pm EDT. Closed.
ISIN
US23725P1003
Symbol
DRIO

DarioHealth Corp. Target price 2026 - Analyst rating & recommendation

DarioHealth Corp. Classifications & Recommendation

Buy
82%
Hold
18%

DarioHealth Corp. Price Target

Target Price $12.24
Price $7.20
Potential
Number of Estimates 7
7 Analysts have issued a price target DarioHealth Corp. 2027 . The average DarioHealth Corp. target price is $12.24. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 11 analysts: 9 Analysts recommend DarioHealth Corp. to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the DarioHealth Corp. stock has an average upside potential 2027 of . Most analysts recommend the DarioHealth Corp. stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 22.36 22.15
17.31% 0.96%
EBITDA Margin -149.91% -79.36%
18.04% 47.06%
Net Margin -276.12% -114.38%
82.19% 58.58%

7 Analysts have issued a sales forecast DarioHealth Corp. 2026 . The average DarioHealth Corp. sales estimate is

$22.1m
unlock
. This is
5.46% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$22.9m 9.09%
unlock
, the lowest is
$21.2m 0.79%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $22.4m 17.31%
2026
$22.1m 0.96%
unlock
2027
$28.7m 29.48%
unlock
2028
$38.3m 33.53%
unlock
2029
$68.7m 79.50%
unlock
2030
$86.3m 25.54%
unlock

5 Analysts have issued an DarioHealth Corp. EBITDA forecast 2026. The average DarioHealth Corp. EBITDA estimate is

$-17.6m
unlock
. This is
40.86% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-16.3m 45.24%
unlock
, the lowest is
$-19.1m 35.72%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-33.5m 32.23%
2026
$-17.6m 47.57%
unlock
2027
$-9.1m 48.29%
unlock
2028
$2.6m 128.32%
unlock
2029
$9.4m 265.00%
unlock
2030
$13.4m 43.02%
unlock

EBITDA Margin

2025 -149.91% 18.04%
2026
-79.36% 47.06%
unlock
2027
-31.69% 60.07%
unlock
2028
6.72% 121.21%
unlock
2029
13.67% 103.42%
unlock
2030
15.57% 13.90%
unlock

7 DarioHealth Corp. Analysts have issued a net profit forecast 2026. The average DarioHealth Corp. net profit estimate is

$-25.3m
unlock
. This is
59.78% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-18.9m 70.02%
unlock
, the lowest is
$-33.5m 46.89%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-61.7m 50.66%
2026
$-25.3m 58.97%
unlock
2027
$-14.0m 44.81%
unlock
2028
$-9.3m 33.83%
unlock
2029
$6.8m 173.62%
unlock
2030
$9.9m 45.08%
unlock

Net Margin

2025 -276.12% 82.19%
2026
-114.38% 58.58%
unlock
2027
-48.74% 57.39%
unlock
2028
-24.15% 50.45%
unlock
2029
9.91% 141.04%
unlock
2030
11.45% 15.54%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -15.50 -3.45
7.24% 77.74%
P/E negative
EV/Sales 3.96

7 Analysts have issued a DarioHealth Corp. forecast for earnings per share. The average DarioHealth Corp. EPS is

$-3.45
unlock
. This is
48.81% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$-2.57 61.87%
unlock
, the lowest is
$-4.56 32.34%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-15.50 7.24%
2026
$-3.45 77.74%
unlock
2027
$-1.90 44.93%
unlock
2028
$-1.26 33.68%
unlock
2029
$0.93 173.81%
unlock
2030
$1.35 45.16%
unlock

P/E ratio

Current -1.07 87.38%
2026
-2.09 95.66%
unlock
2027
-3.78 80.86%
unlock
2028
-5.72 51.32%
unlock
2029
7.76 235.66%
unlock
2030
5.35 31.06%
unlock

Based on analysts' sales estimates for 2026, the DarioHealth Corp. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.17 343.62%
2026
3.96 5.08%
unlock
2027
3.06 22.77%
unlock
2028
2.29 25.11%
unlock
2029
1.28 44.29%
unlock
2030
1.02 20.35%
unlock

P/S ratio

Current 3.36 434.57%
2026
3.19 5.17%
unlock
2027
2.46 22.76%
unlock
2028
1.84 25.11%
unlock
2029
1.03 44.29%
unlock
2030
0.82 20.35%
unlock

Current DarioHealth Corp. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Alliance Global Partners
Locked
Locked
Locked Aug 19 2026
TD Cowen
Locked
Locked
Locked Aug 12 2026
Stifel
Locked
Locked
Locked Mar 20 2026
Litchfield Hills
Locked
Locked
Locked May 19 2025
Stifel
Locked
Locked
Locked Mar 11 2025
Analyst Rating Date
Locked
Alliance Global Partners:
Locked
Locked
Aug 19 2026
Locked
TD Cowen:
Locked
Locked
Aug 12 2026
Locked
Stifel:
Locked
Locked
Mar 20 2026
Locked
Litchfield Hills:
Locked
Locked
May 19 2025
Locked
Stifel:
Locked
Locked
Mar 11 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today